Sign up to save your podcasts
Or
Share Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Obesity Medicine: New Therapies Transform Treatment, Yet Challenges Remain
During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with Katherine Saunders, M.D., Obesity Physician and Co-Founder of FlyteHealth to reflect on the transformation of obesity medicine throughout the past year.
View all episodes
By BMO
4.8
88 ratings
During our second annual BMO Obesity Summit in New York, Evan Seigerman, Managing Director and Senior Research Analyst at BMO Capital Markets and Malcom Hoffman, Senior Equity Research Associate of BioPharma at BMO Capital Markets, sat down with Katherine Saunders, M.D., Obesity Physician and Co-Founder of FlyteHealth to reflect on the transformation of obesity medicine throughout the past year.
More shows like Markets Plus
View all
Freakonomics Radio
32,034 Listeners
Economist Podcasts
4,174 Listeners
Macro Voices
3,070 Listeners
WSJ What’s News
4,349 Listeners
Odd Lots
1,941 Listeners
Better conversations. Better outcomes. | Presented by BMO Global Asset Management
66 Listeners
Wall Street Breakfast
1,039 Listeners
Bold(h)er
2 Listeners
Macro Horizons
79 Listeners
Sustainability Leaders
22 Listeners
Thoughts on the Market
1,294 Listeners
The Journal.
6,086 Listeners
BMO Equity Research IN Tune
6 Listeners
BMO ETFs: Views from the Desk
2 Listeners
SmartLess
57,767 Listeners
BMO Views from the North
4 Listeners
Global Exchanges
1 Listeners
Bloomberg Daybreak: US Edition
78 Listeners
Unhedged
180 Listeners
In the Money with Amber Kanwar
17 Listeners